Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung, Genomic Instability

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Head and Neck Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

NSCLC Stage IIIB~IV

Endometrial Neoplasms

Locally Advanced Cervical Cancer

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Uterine Cervical Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasms, Unknown Primary

Small Cell Lung Carcinoma

SCLC, Extensive Stage

Carcinoma, Non-Small-Cell Lung

Anus Neoplasms

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

Adenocarcinoma, Mucinous, Neoplasm Metastasis, Neoplasms

Recurrent Bladder Urothelial Carcinoma

Carcinoma, Hepatocellular

Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Kidney Neoplasms

Small Cell Lung Cancer Extensive Stage

Neoplasm Metastasis

Advanced Unresectable or Metastatic Solid Malignancy

Carcinoma, Squamous Cell, Esophageal Neoplasms, Neoplasm Metastasis

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Neoplasms

Small Cell Lung Carcinoma

Biliary Tract Neoplasms

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Transitional Cell

Clinical Trials

GFPC 06-2018

SKYSCRAPER-09

DARWINII

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

ATHENA

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

A Phase II Study of Atezolizumab in Combination With Bevacizumab, Carboplatin or Cisplatin, and Pemetrexed for EGFR-mutant Metastatic Non-small Cell Lung Cancer Patients After Failure of EGFR Tyrosine Kinase Inhibitors.

EndoBARR

ATEZOLACC

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

SKYSCRAPER-04

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer

CUPISCO

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

SPACE

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

SCARCE

CABATEN

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

FMT in IT-refractory HCC - FAB-HCC Pilot Study

AUREA

ImmunoCobiVem

ABACUS

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

TREASURE

CRAFT: The NCT-PMO-1602 Phase II Trial

MyTACTIC

Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

VolATIL

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

ALICE

ATEZO-BRAIN

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

RamAtezo-1

Match

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

CeLEBrATE

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

ECLIPSE

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

ATRACTIB

Neoadjuvant Atezolizumab in Localized Bladder Cancer